Evidence map›Paper›PMID 42744251›Full record

ArticleThe Journal of biological chemistry2026

ER quality control of Crumbs2 and Notch proteins by GXYLT1-dependent xylosyl elongation of O-glucose glycans.

Yukihiro Mita, Soomin Cho, Yohei Tsukamoto, Wataru Saiki, Mio Okamura, Yuki Fujita, Nima Niknejad, Daichi Funada, Fuga Suzuki, Kensuke Ohkawa and 9 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yukihiro MitaDepartment of Molecular and Cellular Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Soomin ChoDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA; Development, Disease Models & Therapeutics Graduate Program, Baylor College of Medicine, Houston, Texas, USA.
Yohei TsukamotoDepartment of Molecular and Cellular Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Wataru SaikiDepartment of Molecular and Cellular Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Mio OkamuraDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Yuki FujitaDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Nima NiknejadDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
Daichi FunadaDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Fuga SuzukiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Kensuke OhkawaDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Taiki JoDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Yusuke UrataDepartment of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yuuki KurebayashiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Akira MinamiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan; Department of Functional Morphology, Faculty of Pharmacy, Juntendo University, Chiba, Japan.
Tadanobu TakahashiDepartment of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.
Hideharu HibiDepartment of Oral and Maxillofacial Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Tetsuya OkajimaDepartment of Molecular and Cellular Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan. Electronic address: okajima.tetsuya.c3@f.mail.nagoya-u.ac.jp.
Hamed Jafar-NejadDepartment of Molecular & Human Genetics, Baylor College of Medicine, Houston, Texas, USA; Development, Disease Models & Therapeutics Graduate Program, Baylor College of Medicine, Houston, Texas, USA.
Hideyuki TakeuchiDepartment of Molecular and Cellular Biology, Nagoya University Graduate School of Medicine, Nagoya, Japan; Department of Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan. Electronic address: htakeuchi@u-shizuoka-ken.ac.jp.

Funding

Roles of Glycosylation and Deglycosylation During Animal DevelopmentR35GM130317 · NIGMS · BAYLOR COLLEGE OF MEDICINE · PI Hamed Jafar-Nejad · 2019 to 2026
$3.7M
NIGMS NIH HHS R35 GM130317
6 · The paper itself

Abstract

Protein O-glucosyltransferase 1 (POGLUT1/Rumi) transfers an O-linked glucose (O-Glc) monosaccharide from UDP-Glc to a serine residue in epidermal growth factor (EGF)-like repeats with a specific consensus sequence. In mammals, GXYLT1 and GXYLT2 transfer xylose to this O-Glc monosaccharide. Previous studies showed that Poglut1 deletion in mice leads to embryonic lethality with defects in crumbs family member 2 (CRB2) trafficking and NOTCH1 signaling. Both CRB2 and Notch receptors have multiple EGF repeats with the O-Glc modification site. However, the roles of xylosyl elongation of O-Glc in protein trafficking and mammalian embryonic development are unknown. Here, we demonstrated that xylosyl elongation of O-Glc occurs in the endoplasmic reticulum and comprehensively analyzed O-Glc glycosylation on CRB2, NOTCH1, and NOTCH2 expressed in HEK293T cells by mass spectrometry. Most EGF repeats containing the consensus sequence were modified with O-Glc glycans, while xylosyl elongation varied among different EGF repeats, suggesting EGF repeat-specific regulation. GXYLT1 KO cells showed reduced or lost xylosyl elongation, but GXYLT2 KO cells did not. Cell-based assays demonstrated decreased secretion of substrate proteins in GXYLT1 KO cells, which was rescued by WT GXYLT1. Analysis of Gxylt1 and Gxylt2 KO mice revealed that Gxylt1 deletion, but not Gxylt2 deletion, caused embryonic lethality. Altogether, our data suggest that GXYLT1 plays a major role in xylosyl elongation of O-Glc glycans and thereby contributes to the endoplasmic reticulum quality control and trafficking of CRB2, NOTCH1, and NOTCH2 in HEK293T cells while GXYLT1 and GXYLT2 have distinct biological functions during mouse embryonic development.

Indexed as

crumbsEGF repeatsendoplasmic reticulumER quality controlglycosylationglycosyltransferasemass spectrometryNotchO-glucosylationposttranslational modificationxylose

Identifiers

PMID42744251
PMCPMC13683433

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.